{"id":"https://openalex.org/W2038044906","doi":"https://doi.org/10.1097/00002093-199501002-00007","title":"Clinical Heterogeneity","display_name":"Clinical Heterogeneity","publication_year":1995,"publication_date":"1995-01-01","ids":{"openalex":"https://openalex.org/W2038044906","doi":"https://doi.org/10.1097/00002093-199501002-00007","mag":"2038044906","pmid":"https://pubmed.ncbi.nlm.nih.gov/8534422"},"language":"en","primary_location":{"id":"doi:10.1097/00002093-199501002-00007","doi":"https://doi.org/10.1097/00002093-199501002-00007","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00002093-199501002-00007","pdf_url":null,"source":{"id":"https://openalex.org/S107889856","display_name":"Alzheimer Disease & Associated Disorders","issn_l":"0893-0341","issn":["0893-0341","1546-4156"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alzheimer Disease &amp; Associated Disorders","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5020795055","display_name":"Sarah A. Eagger","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210102348","display_name":"St Charles Hospital","ror":"https://ror.org/00n974j89","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I21862455","https://openalex.org/I4210102348"]},{"id":"https://openalex.org/I4210106957","display_name":"St Mary's Hospital","ror":"https://ror.org/01aysdw42","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I153355300","https://openalex.org/I4210106957"]},{"id":"https://openalex.org/I4210151618","display_name":"National Hospital for Neurology and Neurosurgery","ror":"https://ror.org/048b34d51","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1340918713","https://openalex.org/I4210151618"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Sarah A. Eagger","raw_affiliation_strings":["Academic Department of Old Age Psychiatry, St. Mary's Hospital Medical School, St. Charles Hospital","*Dementia Research Group, St. Mary's Hospital Medical School and The National Hospital for Neurology and Neurosurgery, London, England"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Academic Department of Old Age Psychiatry, St. Mary's Hospital Medical School, St. Charles Hospital","institution_ids":["https://openalex.org/I4210102348"]},{"raw_affiliation_string":"*Dementia Research Group, St. Mary's Hospital Medical School and The National Hospital for Neurology and Neurosurgery, London, England","institution_ids":["https://openalex.org/I4210106957","https://openalex.org/I4210151618"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5114376006","display_name":"Richard J. Harvey","orcid":"https://orcid.org/0000-0001-7796-0059","observed_orcids":["https://orcid.org/0000-0001-7796-0059","https://orcid.org/0000-0002-6942-8975"]},"institutions":[{"id":"https://openalex.org/I4210102348","display_name":"St Charles Hospital","ror":"https://ror.org/00n974j89","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I21862455","https://openalex.org/I4210102348"]},{"id":"https://openalex.org/I4210106957","display_name":"St Mary's Hospital","ror":"https://ror.org/01aysdw42","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I153355300","https://openalex.org/I4210106957"]},{"id":"https://openalex.org/I4210151618","display_name":"National Hospital for Neurology and Neurosurgery","ror":"https://ror.org/048b34d51","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1340918713","https://openalex.org/I4210151618"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Richard J. Harvey","raw_affiliation_strings":["Academic Department of Old Age Psychiatry, St. Mary's Hospital Medical School, St. Charles Hospital","*Dementia Research Group, St. Mary's Hospital Medical School and The National Hospital for Neurology and Neurosurgery, London, England"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Academic Department of Old Age Psychiatry, St. Mary's Hospital Medical School, St. Charles Hospital","institution_ids":["https://openalex.org/I4210102348"]},{"raw_affiliation_string":"*Dementia Research Group, St. Mary's Hospital Medical School and The National Hospital for Neurology and Neurosurgery, London, England","institution_ids":["https://openalex.org/I4210106957","https://openalex.org/I4210151618"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":3.1276,"has_fulltext":false,"cited_by_count":27,"citation_normalized_percentile":{"value":0.91118744,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"9","issue":null,"first_page":"37","last_page":"37"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.8711000084877014,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.8711000084877014,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.08609999716281891,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.03970000147819519,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.9520000219345093},{"id":"https://openalex.org/keywords/clinical-heterogeneity","display_name":"clinical heterogeneity","score":0.9660000205039978},{"id":"https://openalex.org/keywords/cholinergic-therapy","display_name":"cholinergic therapy","score":0.8650000095367432},{"id":"https://openalex.org/keywords/cholinesterase-inhibitors","display_name":"cholinesterase inhibitors","score":0.9869999885559082},{"id":"https://openalex.org/keywords/tacrine","display_name":"tacrine","score":0.9440000057220459},{"id":"https://openalex.org/keywords/treatment-response-prediction","display_name":"treatment response prediction","score":0.7440000176429749},{"id":"https://openalex.org/keywords/patient-subgroups","display_name":"patient subgroups","score":0.6140000224113464},{"id":"https://openalex.org/keywords/orthostatic-blood-pressure","display_name":"orthostatic blood pressure","score":0.7459999918937683},{"id":"https://openalex.org/keywords/pupil-dilation","display_name":"pupil dilation","score":0.9829999804496765},{"id":"https://openalex.org/keywords/electroencephalography","display_name":"EEG","score":0.9089999794960022},{"id":"https://openalex.org/keywords/functional-neuroimaging","display_name":"functional neuroimaging","score":0.8830000162124634},{"id":"https://openalex.org/keywords/psychometric-tests","display_name":"psychometric tests","score":0.7250000238418579},{"id":"https://openalex.org/keywords/trial-design","display_name":"trial design","score":0.46799999475479126}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7304205894470215},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.6440268158912659},{"id":"https://openalex.org/C2779046751","wikidata":"https://www.wikidata.org/wiki/Q421076","display_name":"Tacrine","level":4,"score":0.5850925445556641},{"id":"https://openalex.org/C31896038","wikidata":"https://www.wikidata.org/wiki/Q415635","display_name":"Cholinesterase","level":2,"score":0.5047446489334106},{"id":"https://openalex.org/C39920043","wikidata":"https://www.wikidata.org/wiki/Q786278","display_name":"Neurochemistry","level":3,"score":0.4880613088607788},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.42973339557647705},{"id":"https://openalex.org/C73787029","wikidata":"https://www.wikidata.org/wiki/Q7104929","display_name":"Orthostatic vital signs","level":3,"score":0.42532408237457275},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.39858749508857727},{"id":"https://openalex.org/C16568411","wikidata":"https://www.wikidata.org/wiki/Q83042","display_name":"Neurology","level":2,"score":0.2981969118118286},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.290746808052063},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.1765771508216858},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.1284390687942505},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.0},{"id":"https://openalex.org/C2778816929","wikidata":"https://www.wikidata.org/wiki/Q22676679","display_name":"Acetylcholinesterase","level":3,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011336","descriptor_name":"Probability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013619","descriptor_name":"Tacrine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018678","descriptor_name":"Cholinergic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1097/00002093-199501002-00007","doi":"https://doi.org/10.1097/00002093-199501002-00007","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00002093-199501002-00007","pdf_url":null,"source":{"id":"https://openalex.org/S107889856","display_name":"Alzheimer Disease & Associated Disorders","issn_l":"0893-0341","issn":["0893-0341","1546-4156"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alzheimer Disease &amp; Associated Disorders","raw_type":"journal-article"},{"id":"pmid:8534422","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8534422","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alzheimer disease and associated disorders","raw_type":"Journal Article"},{"id":"pmh:oai:dro.deakin.edu.au:DU:30128051","doi":null,"is_oa":false,"landing_page_url":"https://journals.lww.com/alzheimerjournal/pages/articleviewer.aspx?year=1995&amp;issue=01002&amp;article=00007&amp;type=abstract#pdf-link","pdf_url":"https://journals.lww.com/alzheimerjournal/pages/articleviewer.aspx?year=1995&amp;issue=01002&amp;article=00007&amp;type=abstract#pdf-link","source":{"id":"https://openalex.org/S4306401102","display_name":"Own your potential (DEAKIN)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I149704539","host_organization_name":"Deakin University","host_organization_lineage":["https://openalex.org/I149704539"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Journal Article"},{"id":"pmh:oai:figshare.com:article/20795212","doi":null,"is_oa":false,"landing_page_url":"https://figshare.com/articles/journal_contribution/Clinical_heterogeneity_responders_to_cholinergic_therapy/20795212","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Text"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7036372450","https://openalex.org/W2990162587","https://openalex.org/W36571120","https://openalex.org/W2056913646","https://openalex.org/W1969926447","https://openalex.org/W2409554366","https://openalex.org/W1494380443","https://openalex.org/W7034082441","https://openalex.org/W2069046132","https://openalex.org/W2092237773"],"abstract_inverted_index":{"Clinical":[0],"Alzheimer":[1],"disease":[2],"(AD)":[3],"is":[4,10,24,55,87,200,225,238],"a":[5,16,28,46,90,122,163],"heterogeneous":[6],"disorder,":[7],"and":[8,34,54,86,149,189,209],"it":[9],"possible":[11],"to":[12,31,57,69,107,115,117,231],"subgroup":[13],"patients":[14,85,110,207],"by":[15,202],"number":[17,47,164],"of":[18,48,51,75,84,93,101,129,139,147,162,165,168,176,206,214],"different":[19],"criteria.":[20],"One":[21],"such":[22],"subgrouping":[23],"those":[25,35,109],"who":[26,36,111],"have":[27],"positive":[29],"response":[30,170],"cholinergic":[32,118],"therapy":[33,119],"do":[37],"not.":[38],"This":[39],"phenomenon":[40],"has":[41],"been":[42],"clearly":[43],"recognised":[44],"in":[45,61,125,141,144,150,155],"therapeutic":[49,233],"trials":[50,148],"cholinesterase":[52,67],"inhibitors":[53],"likely":[56,114],"be":[58,70,121,223],"an":[59],"issue":[60,138],"clinical":[62,102,127],"practice.":[63],"Tacrine,":[64],"the":[65,73,126,137,145,151,160,174,184,203,210,215],"first":[66],"inhibitor":[68],"approved":[71],"for":[72],"treatment":[74],"AD,":[76],"has,":[77],"at":[78],"best,":[79],"modest":[80],"effects":[81],"on":[82],"20-50%":[83],"associated":[88],"with":[89],"high":[91],"frequency":[92],"side":[94],"effects,":[95],"including":[96],"liver":[97],"transaminitis.":[98],"The":[99,218],"potential":[100,169],"tests":[103],"or":[104],"other":[105],"investigations":[106],"identify":[108],"are":[112,197,229],"more":[113],"respond":[116],"would":[120],"valuable":[123],"aid":[124],"use":[128,175],"these":[130],"therapies.":[131],"In":[132],"this":[133],"article":[134],"we":[135],"review":[136],"heterogeneity":[140],"patient":[142],"populations,":[143],"design":[146],"pharmacological":[152],"compounds":[153],"used":[154],"trials.":[156],"We":[157],"then":[158],"summarise":[159],"findings":[161],"small":[166,204],"studies":[167],"predictors,":[171],"which":[172],"include":[173],"psychometric":[177],"tests,":[178],"orthostatic":[179],"blood":[180],"pressure,":[181],"pupillary":[182],"dilation,":[183],"electroencephalogram,":[185],"cerebrospinal":[186],"fluid":[187],"neurochemistry,":[188],"techniques":[190],"involving":[191],"functional":[192],"imaging.":[193],"Although":[194],"some":[195],"results":[196],"promising,":[198],"generalisability":[199],"limited":[201],"numbers":[205],"studied":[208],"frequent":[211],"open":[212],"nature":[213],"designs":[216],"used.":[217],"main":[219],"conclusion":[220],"that":[221,226],"can":[222],"drawn":[224],"adequate":[227],"doses":[228],"required":[230],"achieve":[232],"plasma":[234],"levels":[235],"before":[236],"nonresponse":[237],"accepted.":[239]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}
